homefeedbacksupportlog on 2-Dec-2008 
  Search
 
   
 
  Browse
ALL OF MEDICINE

Oncology
Breast Diseases: Benign & Malignant
Cancer in the Elderly
Genitourinary Cancers
Gynecological Cancers
Head & Neck Cancers
Oncology Agents
Pediatric Oncology
Sarcomas
Supportive & Palliative Cancer Care
Related Sections
Adrenal Cortex
Gastrointestinal Cancers
Leukemia & Proliferative Disorders of Hematic Cells
Lung Cancer
Lymphomas & Myelomas
Multiple Endocrine Disorders & Neoplasias
Neuro-Oncology
Skin Cancers (inc. Melanoma & Lymphoma)

profile subject selected for My F1000 Medicine

Browse > Oncology > Genitourinary Cancers
Current Top 10 by F1000 Factor / All Time Top 10 by F1000 Factor / Most viewed
(from all journals) / Most viewed
(from specialty journals) / Hidden jewels		Page 1 of 8. Select Page: 1 2 3 4 5 6 7 8 >>
Display 10 / 20 / 50 papers per page

printer friendly 
to email [Help]

Recommended
F1000 Factor 3.0

Tech Advance
 Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer.
Braeckman J, Autier P, …, Egevad L, Emberton M
BJU Int 2008 Feb 101(3):293-8 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Thomas Polascik with Matvey Tsivian
Evaluated 26 Nov 2008

Recommended
F1000 Factor 3.0

New Finding
 Sorafenib for older patients with renal cell carcinoma: subset analysis from a randomized trial.
Eisen T, Oudard S, …, Escudier B, TARGET Study Group
J Natl Cancer Inst 2008 Oct 15 100(20):1454-63 [abstract on PubMed] [related articles] [FREE full text]
Selected by | David M Nanus
Evaluated 19 Nov 2008

Must Read
F1000 Factor 6.0

New Finding
 Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma.
Motzer RJ, Bukowski RM, …, Baum CM, Kattan MW
Cancer 2008 Oct 1 113(7):1552-8 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | David M Nanus
Evaluated 19 Nov 2008

Recommended
F1000 Factor 3.0

Confirmation
New Finding
 An illustration of the potential for mapping MRI/MRS parameters with genetic over-expression profiles in human prostate cancer.
Lenkinski RE, Bloch BN, …, Rofsky NM, Gaston SM
MAGMA 2008 Aug 28 [abstract on PubMed] [related articles] [full text]
Selected by | Hedvig Hricak with Amita Shukla-Dave
Evaluated 13 Nov 2008

Must Read
F1000 Factor 4.8

Hypothesis
New Finding
 Seeding and propagation of untransformed mouse mammary cells in the lung.
Podsypanina K, Du YC, …, Hambardzumyan D, Varmus H
Science 2008 Sep 26 321(5897):1841-4 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Larry Suva / Christos Sotiriou with Michail Ignatiadis
First evaluation 7 Nov 2008 | Latest evaluation 11 Nov 2008


Recommended
F1000 Factor 3.0

New Finding
 Bladder cancer detection with CT urography in an Academic Medical Center.
Sadow CA, Silverman SG, O'Leary MP, Signorovitch JE
Radiology 2008 Oct 249(1):195-202 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Seth Lerner with John Weedin
Evaluated 5 Nov 2008

Must Read
F1000 Factor 6.0

Confirmation
New Finding
 Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment.
Köllermann J, Weikert S, …, Rau T, Pantel K
J Clin Oncol 2008 Oct 20 26(30):4928-33 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Charles Ryan
Evaluated 4 Nov 2008

Must Read
F1000 Factor 6.0

Confirmation
 Residual prostate cancer after radiotherapy: a study of radical cystoprostatectomy specimens.
Kaplan DJ, Crispen PL, …, Horwitz EM, Uzzo RG
Urology 2008 Sep 72(3):654-8 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Juan Palou Redorta with Guillermo Urdaneta Pignalosa
Evaluated 31 Oct 2008

Recommended
F1000 Factor 3.0

Confirmation
New Finding
 Sequence variant on 8q24 confers susceptibility to urinary bladder cancer.
Kiemeney LA, Thorlacius S, …, Rafnar T, Stefansson K
Nat Genet 2008 Sep 14 [abstract on PubMed] [related articles] [full text]
Selected by | Ashish Kamat with Robert Svatek
Evaluated 24 Oct 2008


Recommended
F1000 Factor 3.0

Confirmation
 A phase II study investigating the re-induction of endocrine sensitivity following chemotherapy in androgen-independent prostate cancer.
Shamash J, Davies A, …, Oliver T, Powles T
Br J Cancer 2008 Jan 15 98(1):22-4 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Yoshihiko Hirao with Kiyohide Fujimoto
Evaluated 22 Oct 2008


top of pagePage 1 of 8. Select Page: 1 2 3 4 5 6 7 8 >>
Display 10 / 20 / 50 papers per page

© 2008 Medicine Reports Ltd unless otherwise stated. < info@f1000.com >   Terms and conditions   Legal info